Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
<h4>Background</h4>Group B Streptococcus (GBS) can cause invasive disease (iGBS) in young infants, typically presenting as sepsis or meningitis, and is also associated with stillbirth and preterm birth. GBS vaccines are under development, but their potential health impact and cost-effect...
Saved in:
| Main Authors: | Simon R Procter, Bronner P Gonçalves, Proma Paul, Jaya Chandna, Farah Seedat, Artemis Koukounari, Raymond Hutubessy, Caroline Trotter, Joy E Lawn, Mark Jit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-03-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004068&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
by: Bronner P Gonçalves, et al.
Published: (2021-06-01) -
Estimating the Public Health and Economic Impact of Immunisation with Nirsevimab or Maternal Immunisation for the Prevention of RSV-Related Outcomes Over Infants’ First RSV Season in the UK
by: Mersha Chetty, et al.
Published: (2025-07-01) -
Technology for global immunisation
by: The Lancet Digital Health
Published: (2025-05-01) -
IMMUNISATION UPDATE 2011 (IN RUSSIAN)
by: E. David G. McIntosh
Published: (2011-08-01) -
IMMUNISATION UPDATE 2011 (IN ENGLISH)
by: E. David G. McIntosh
Published: (2011-08-01)